Abstract
Background: The composition and function of the gut microbiome may influence the activity of systemic anti-cancer therapies. However, it is not yet known whether and how the gut microbiome impacts on chemo-sensitivity in breast cancer. To address this we have investigated associations between short chain fatty acids (SCFAs), key functional metabolites of the gut microbiome, and pCR.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
